Showing results (131-140 of 209) with videos related to
Sort By:
Pageof 21
Cancer Prevention Research (Philadelphia, Pa.)|October 25, 2013
A multiantigen vaccine targeting neu, IGFBP-2, and IGF-IR prevents tumor progression in mice with preinvasive breast diseaseMary L Disis, Ekram Gad, Daniel R Herendeen, et al.Proteomics. Clinical Applications|February 13, 2013
Proteomic profiling of the autoimmune response to breast cancer antigens uncovers a suppressive effect of hormone therapyTimothy Chao, Jon J Ladd, Ji Qiu, et al.ACS Nano|February 14, 2012
Targeting of primary breast cancers and metastases in a transgenic mouse model using rationally designed multifunctional SPIONsForrest M Kievit, Zachary R Stephen, Omid Veiseh, et al.Blood|November 22, 2007
The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunityMarshall D Behrens, Wolfgang M Wagner, Christopher J Krco, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 24, 2010
Treatment failure of a TLR-7 agonist occurs due to self-regulation of acute inflammation and can be overcome by IL-10 blockadeHailing Lu, Wolfgang M Wagner, Ekram Gad, et al.JAMA Oncology|January 24, 2017
Topical Imiquimod Plus Nab-paclitaxel for Breast Cancer Cutaneous Metastases: A Phase 2 Clinical TrialLupe G Salazar, Hailing Lu, Jessica L Reichow, et al.Clinical Pharmacology and Therapeutics|December 14, 2004
The effect of clarithromycin, fluconazole, and rifabutin on dapsone hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283)Helen R Winter, Carol B Trapnell, John T Slattery, et al.JAMA|July 6, 2006
Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trialPaul B Watkins, Neil Kaplowitz, John T Slattery, et al.Clinical Pharmacology and Therapeutics|October 8, 2004
The effect of clarithromycin, fluconazole, and rifabutin on sulfamethoxazole hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283)Helen R Winter, Carol B Trapnell, John T Slattery, et al.Journal for Immunotherapy of Cancer|November 9, 2024
Magnitude of antigen-specific T-cell immunity the month after completing vaccination series predicts the development of long-term persistence of antitumor immune responseJohn B Liao, James Y Dai, Jessica L Reichow, et al.Pageof 21